Macquarie Group LTD Madrigal Pharmaceuticals, Inc. Transaction History

Macquarie Group LTD

$90.3 Billion
Q3 2024

A detailed history of Macquarie Group LTD transactions in Madrigal Pharmaceuticals, Inc. stock. As of the latest transaction made, Macquarie Group LTD holds 15,000 shares of MDGL stock, worth $4.81 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

15,000

Previous 28,500 47.37%

Holding current value

$4.81 Million

Previous $7.98 Million 60.13%

% of portfolio

0.0%

Previous 0.01%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$212.22 - $292.96 $2.86 Million - $3.95 Million	-13,500 Reduced 47.37%	15,000 $3.18 Million
Q2 2024 Aug 09, 2024	SELL	$193.33 - $291.99 $5.89 Million - $8.89 Million	-30,457 Reduced 51.66%	28,500 $7.98 Million
Q1 2024 May 14, 2024	BUY	$171.37 - $283.23 $5.22 Million - $8.63 Million	30,457 Added 106.87%	58,957 $15.7 Million
Q4 2022 Feb 21, 2023	SELL	$58.39 - $296.54 $49,573 - $251,762	-849 Reduced 2.89%	28,500 $8.27 Million
Q3 2022 Nov 14, 2022	SELL	$60.57 - $79.51 $8,782 - $11,528	-145 Reduced 0.49%	29,349 $1.92 Million
Q3 2021 Nov 12, 2021	BUY	$78.35 - $105.02 $58,214 - $78,029	743 Added 2.58%	29,494 $2.35 Million
Q1 2021 May 14, 2021	SELL	$108.54 - $125.2 $7,489 - $8,638	-69 Reduced 0.24%	28,751 $3.36 Million
Q2 2020 Aug 11, 2020	BUY	$60.13 - $125.71 $19,241 - $40,227	320 Added 1.12%	28,820 $3.26 Million
Q2 2019 Aug 14, 2019	SELL	$91.13 - $142.5 $1.1 Million - $1.72 Million	-12,100 Reduced 29.8%	28,500 $2.99 Million
Q1 2019 May 15, 2019	BUY	$103.48 - $143.84 $155,220 - $215,760	1,500 Added 3.84%	40,600 $5.09 Million
Q4 2018 Feb 15, 2019	BUY	$94.77 - $215.54 $606,528 - $1.38 Million	6,400 Added 19.57%	39,100 $4.41 Million
Q3 2018 Nov 15, 2018	BUY	$207.3 - $300.31 $1.84 Million - $2.67 Million	8,900 Added 37.39%	32,700 $7 Million
Q2 2018 Aug 14, 2018	BUY	$101.55 - $313.9 $2.42 Million - $7.47 Million	23,800 New	23,800 $6.66 Million

Others Institutions Holding MDGL

# of Institutions

296

Shares Held

22M

Call Options Held

819K

Put Options Held

640K

View Full List

About MADRIGAL PHARMACEUTICALS, INC.

Ticker MDGL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 17,103,400
Market Cap $5.49B
Description
Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III c...

More about MDGL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Macquarie Group LTD, based on Form 13F filings with the SEC.

News

Stay updated on Macquarie Group LTD with notifications on news.

Account

Macquarie Group LTD Madrigal Pharmaceuticals, Inc. Transaction History